We outline the market outlook for AI-powered drug discovery in the pharma and clinical research industry — from investment trends, to leading companies, to recommendations for the players in the space.
What is AI-powered drug discovery?
Artificial intelligence (AI)-powered drug discovery companies in the pharma market are analyzing data, such as clinical trial data, electronic health records, omics data, cellular images, and more, to discover novel drug candidates. Machine learning alone is no longer a differentiator. Startups are increasingly incorporating laboratory automation and experimentation to create high-quality biological data to train their algorithms.
<![endif]-->
<script charset="utf-8" type="text/javascript" src=https://www.cbinsights.com/research/market-trend-report-ai-powered-drug-discovery-pharma-cro-leaders/"//js.hsforms.net/forms/v2.js">
<script>
hbspt.forms.create({
onFormReady: function ($form) {
window.ClearbitForHubspot.addForm($form);
},
region: "na1",
portalId: "763793",
formId: "90955808-0135-4f5d-b9bc-c9c16290b2f4"
});
</script></div></div></div>"}" data-sheets-userformat="{"2":6657,"3":{"1":0},"12":0,"14":{"1":2,"2":4473924},"15":"Arial"}">FREE DOWNLOAD: THE COMPLETE DIGITAL HEALTH 150 LIST
Features & capabilities
AI-powered drug discovery provides pharma and clinical research organization (CRO) leaders with several capabilities, including:
- Navigation of complex patient data
- Advanced AI-based platforms
- New design and compound generation technology
- Synthetic accessibility
- Real-time monitoring of data gathering processes
Want the full expert post? Become a CB Insights customer.
If you’re already a customer, log in here.
